Mammalian cell culture is and will remain the principle vehicle for protein production in upstream manufacturing, according to Florian Wurm, Ph.D., professor of biochemistry at the University of ...

Proteins represent a significant portion of the biopharmaceutical industries’ manufacturing repertoire—meaning that by extension, effective protein production and purification techniques are essential ...

Real-time and in-line accurate measuring of protein (monoclonal antibody, or mAb) concentration has been shown across a wide dynamic range (0–135 g/L) through the ...

The demand for complex therapeutic proteins, is rapidly accelerating, with the bispecific market alone projected to grow from $12B in 2024 to $50B by 2030. While these atypical molecules offer ...

Engineers devised a way to purify protein drugs during manufacturing. Their approach, which uses nanoparticles to rapidly crystallize proteins, could help make protein drugs more affordable and ...

Industrial yeasts are a powerhouse of protein production, used to manufacture vaccines, biopharmaceuticals, and other useful compounds. In a new study, MIT chemical engineers have harnessed artificial ...

With biomanufacturing often a limiting factor for drug developers, Canada’s Future Fields is heralding its bug-based approach to protein production as a potential salve. Now, after several years spent ...

Make faster, more confident decisions while improving consistency and control in therapeutic protein manufacturing. This webinar explores how real-time, in-line process monitoring delivers actionable, ...

Alt-protein companies scaling their fermentation processes beyond the lab face numerous challenges that require them to think through production processes, raw ingredients, and the design of a ...

Biotech company LanzaTech is making strides in global microbial fermentation protein production with the launch of its proprietary LanzaTech Nutritional Protein (LNP), in collaboration with ...